Clinical Trial Update: Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Sanofi Pasteur's CYD Dengue Vaccine in healthy Singaporean subjects; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Disease
• Dengue Fever
• Dengue Hemorrhagic Fever
• Dengue Virus Infection

Drugs mentioned

• CYD Dengue vaccine (dengue vaccine, live attenuated tetravalent)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED | Results posted: 2019-07-29